The Utility of TRBC1 Immunohistochemistry in the Evaluation of T-Cell Lymphomas.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
5 cases, most of which were follicular helper T-cell lymphomas, angioimmunoblastic type/nodal T follicular helper cell lymphomas, angioimmunoblastic type (AITL).
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
In differentiating T-cell lymphoma from reactive lymphoid tissue, it had a sensitivity of 88% and specificity of 97%. Thus, TRBC1 IHC is a useful, rapid, and inexpensive tool in the diagnosis of T-cell lymphomas.
T-cell receptor β chain constant region 1 (TRBC1) is a useful marker for the detection of clonal T-cell populations and has been used in flow cytometry, with limited data on its utility as an immunohi
- Sensitivity 88%
- Specificity 97%
APA
Patwardhan PP, Al-Attar A, et al. (2025). The Utility of TRBC1 Immunohistochemistry in the Evaluation of T-Cell Lymphomas.. The American journal of surgical pathology, 49(12), 1258-1265. https://doi.org/10.1097/PAS.0000000000002455
MLA
Patwardhan PP, et al.. "The Utility of TRBC1 Immunohistochemistry in the Evaluation of T-Cell Lymphomas.." The American journal of surgical pathology, vol. 49, no. 12, 2025, pp. 1258-1265.
PMID
40693682
Abstract
T-cell receptor β chain constant region 1 (TRBC1) is a useful marker for the detection of clonal T-cell populations and has been used in flow cytometry, with limited data on its utility as an immunohistochemical marker. We evaluated TRBC1 by immunohistochemistry (IHC) in 42 CD3-positive, T-cell receptor alpha beta-positive T-cell lymphomas and compared their expression pattern to a control cohort of 35 reactive lymph nodes and tonsils. TRBC1 restriction was evident in 37/42 (88%) lymphomas but indeterminate in 5 cases, most of which were follicular helper T-cell lymphomas, angioimmunoblastic type/nodal T follicular helper cell lymphomas, angioimmunoblastic type (AITL). 34/35 (97%) control cases had ∼50% as much TRBC1 staining as CD3; however, one tonsil, while not TRBC1 restricted, had much less staining than CD3, which was confirmed by TRBC1 flow cytometry. TRBC1 IHC was helpful in demonstrating clonality in most T-cell lymphomas, including all cases lacking flow cytometric studies, and in 2 cases without definite molecular evidence of clonality. In differentiating T-cell lymphoma from reactive lymphoid tissue, it had a sensitivity of 88% and specificity of 97%. Thus, TRBC1 IHC is a useful, rapid, and inexpensive tool in the diagnosis of T-cell lymphomas.